Skip to main content
. 2015 Jun;6(3):128–141. doi: 10.1177/2040620715576662

Figure 1.

Figure 1.

Mechanisms of action of the bromodomain and extra-terminal (BET) protein inhibitors: main genes and gene signatures targeted in acute leukaemia, myeloma, lymphoma and myeloproliferative neoplasms (MPN) are shown. SE, super-enhancer; TSS, transcription starting sites.